Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-12-22 4:02 pm Purchase |
2022-12-15 | 13G | Astria Therapeutics, Inc. ATXS |
Deep Track Capital, LP | 1,816,531 7.320% |
1,816,531 (New Position) |
Filing History |
| 2022-12-21 4:30 pm Purchase |
2022-12-19 | 13D | Astria Therapeutics, Inc. ATXS |
PERCEPTIVE ADVISORS LLC | 2,487,802 9.900% |
2,487,802 (New Position) |
Filing History |
| 2022-12-21 2:12 pm Purchase |
2022-12-15 | 13G | Astria Therapeutics, Inc. ATXS |
Altium Capital Management LLC | 1,355,372 5.200% |
1,355,372 (New Position) |
Filing History |
| 2022-11-14 4:43 pm Sale |
2022-11-14 | 13G | Astria Therapeutics, Inc. ATXS |
RA CAPITAL MANAGEMENT LLC | 0 0.000% |
-1,262,193 (Position Closed) |
Filing History |
| 2022-09-08 4:00 pm Purchase |
2022-08-31 | 13G | Astria Therapeutics, Inc. ATXS |
Vivo Opportunity LLC | 1,000,000 7.100% |
1,000,000 (New Position) |
Filing History |
| 2022-09-02 4:10 pm Purchase |
2022-08-23 | 13G | Astria Therapeutics, Inc. ATXS |
Cormorant Asset Management LP | 1,200,000 5.380% |
1,200,000 (New Position) |
Filing History |
| 2022-02-24 5:23 pm Purchase |
2021-12-31 | 13G | Astria Therapeutics, Inc. ATXS |
BlackRock Inc. BLK |
53,073 0.400% |
53,073 (New Position) |
Filing History |
| 2022-02-14 4:11 pm Purchase |
2021-12-31 | 13G | Astria Therapeutics, Inc. ATXS |
RA CAPITAL MANAGEMENT LLC | 1,262,193 9.700% |
1,262,193 (New Position) |
Filing History |
| 2022-02-08 4:31 pm Sale |
2021-12-31 | 13G | Astria Therapeutics, Inc. ATXS |
Fairmount Funds Management LLC | 911,736 7.000% |
-62,869 (-6.45%) |
Filing History |
| 2022-01-06 8:15 pm Purchase |
2022-01-06 | 13G | Astria Therapeutics, Inc. ATXS |
Rosalind Advisors, Inc. | 653,438 5.000% |
653,438 (New Position) |
Filing History |
| 2021-09-22 9:54 pm Unchanged |
2021-09-20 | 13D | Astria Therapeutics, Inc. ATXS |
Viridian LLC | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2021-09-22 3:57 pm Purchase |
2021-09-20 | 13G | Astria Therapeutics, Inc. ATXS |
Fairmount Funds Management LLC | 974,605 7.600% |
974,605 (New Position) |
Filing History |
| 2021-07-09 2:38 pm Purchase |
2021-06-30 | 13G | Astria Therapeutics, Inc. ATXS |
FEDERATED HERMES INC. FHI |
260,456 1.990% |
39 (+0.01%) |
Filing History |
| 2021-06-25 5:01 pm Purchase |
2021-06-08 | 13D | Astria Therapeutics, Inc. ATXS |
Xontogeny LLC | 1,281,198 9.900% |
1,281,198 (New Position) |
Filing History |
| 2021-06-25 5:01 pm Purchase |
2021-06-08 | 13D | Astria Therapeutics, Inc. ATXS |
PERCEPTIVE ADVISORS LLC | 1,281,198 9.900% |
868,377 (+210.35%) |
Filing History |
| 2021-06-17 1:41 pm Purchase |
2021-06-08 | 13D | Astria Therapeutics, Inc. ATXS |
Viridian LLC | 1,281,198 9.990% |
1,281,198 (New Position) |
Filing History |
| 2021-06-17 1:32 pm Purchase |
2021-06-08 | 13G | Astria Therapeutics, Inc. ATXS |
Fairmount Funds Management LLC | 682,028 5.300% |
682,028 (New Position) |
Filing History |
| 2021-06-15 4:32 pm Purchase |
2021-06-08 | 13G | Astria Therapeutics, Inc. ATXS |
RA CAPITAL MANAGEMENT LLC | 957,624 7.500% |
957,624 (New Position) |
Filing History |
| 2021-02-16 07:33 am Sale |
2020-12-31 | 13G | Astria Therapeutics, Inc. ATXS |
Altium Capital Management LLC | 41,667 1.200% |
-112,500 (-72.97%) |
Filing History |
| 2021-02-16 06:26 am Sale |
2020-12-31 | 13G | Astria Therapeutics, Inc. ATXS |
Corriente Advisors LLC | 0 0.000% |
-134,097 (Position Closed) |
Filing History |